alt.support.diabetes

the official website for the newsgroup

Welcome to Alt-Support-Diabetes

Alt-Support-Diabetes (ASD) is an online support group for diabetics, their families and friends. We use this forum to freely share our personal experiences, knowledge, hopes, successes and frustrations concerning diabetes and it's impact on our lives. Currently we are using three major forums: the newsgroup alt.support.diabetes, our IRC chat room, and this website.

Newsgroups are one of the oldest parts of the internet called UseNet. It even pre-dates the World Wide Web. Currently there are over 70,000 individual newsgroups.

We encourage everyone to first read the newsgroups FAQ. It explains the few do's and don'ts and some basic information about posting to a UseNet forum such as ours.

Diabetes in the News

  • Significant increase in type 1 diabetes rates among non-Hispanic white youth
    The rate of non-Hispanic white youth diagnosed with type 1 diabetes increased significantly from 2002 to 2009 in all but the youngest age group of children, according to a new study.
  • New test could identify infants with rare insulin disease
    A rare form of a devastating disease that causes low blood sugar levels in babies and infants may now be recognized earlier thanks to a new test. Congenital hyperinsulinism starves a baby's brain of blood sugar and can lead to lifelong brain damage or permanent disability. The condition occurs when specialised cells in the pancreas release too much insulin which causes frequent low sugar episodes -- the clinical opposite of diabetes. Treatment includes drugs to reduce insulin release but in the most serious cases the pancreas is removed.
  • Protecting us from our cells: Research could speed trials to treat auto-immune diseases
    Our immune system defends us from harmful bacteria and viruses, but, if left unchecked, the cells that destroy those invaders can turn on the body itself, causing auto-immune diseases like type-1 diabetes or multiple sclerosis. A molecule called insulin-like growth factor-1 (IGF-1) boosts the body’s natural defense against this ‘friendly fire’, scientists have found. The findings are especially exciting because IGF-1 is already approved for use in patients, which could speed up the move to clinical trials for treating auto-immune diseases.